Animal Models of Depression
抑郁症动物模型
基本信息
- 批准号:7553550
- 负责人:
- 金额:$ 41.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-29 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:AgonistAnimal ModelAnimalsAntidepressive AgentsBehaviorBehavioralBipolar DisorderBreedingBupropionChronicCorticotropin-Releasing Hormone ReceptorsDevelopmentDrug usageExposure toFoodHome environmentHumanLaboratoriesLaboratory ResearchManicMental DepressionModelingMood DisordersMotor ActivityNamesNeonatalNumbersPharmaceutical PreparationsPhosphodiesterase InhibitorsPreclinical Drug EvaluationProceduresPsychotropic DrugsRattusRecoveryRodent ModelScreening procedureStandards of Weights and MeasuresStressStudy modelsSwimmingSymptomsTechniquesTestingWater consumptionWeekdaydepressive symptomsdrug efficacydrug testingimprovedmaternal separationreceptor
项目摘要
The proposed project will examine effects of a number of drugs supplied by GlaxoSmithKline,
assessing these drugs for their potential antidepressant capability. Assessment will be made
primarily using two new animal models. One of these is a new screening technique for effective
antidepressant treatments that appears to be more selective for detecting effective antidepressant drugs than is previously-developed screening techniques. This model uses a selectively-bred line of rats, the Swim-test Susceptible rat (or Susceptible rat), that shows heightened vulnerability to having its active behavior in a swim test reduced when it is exposed to a mild stress situation prior to the swim test. Chronic treatment with antidepressant drugs has been found to block this vulnerability; chronic treatment with other psychoactive drugs is without effect. Thus, this test appears usable to detect antidepressant drugs, and to discriminate these from other psychoactive drugs. The second model is a new rodent model of depression in which the animals show long-lasting symptoms of depression (i.e., 20-35 days duration) following a single exposure to a stressful situation. In previously-existing rodent models, depression-like symptoms have been transitory (i.e., lasted 2-4 days); thus, previous models did not allow drugs to be administered after onset of depressive symptoms so that recovery could be observed as it occurs in humans. This new model permits this to be done. The model in which long-lasting symptoms occur uses another selectively-bred rat- the Hyperactive rat. In addition to testing of drugs in these models, drugs also will be tested in a standard Porsolt swim test. Finally, additional development of animal models is proposed. In this regard, we will (a) attempt to further perfect the Hyperactive rat as a potential model for study of bipolar disorder, and (b) subject our selectively-bred rats to maternal separation as a possible means of producing improved models of affective disorders.
拟议的项目将检查葛兰素史克提供的多种药物的效果,
评估这些药物的潜在抗抑郁能力。将进行评估
主要使用两种新的动物模型。其中之一是一种新的有效筛选技术
与之前开发的筛选技术相比,抗抑郁治疗似乎在检测有效抗抑郁药物方面更具选择性。该模型使用选择性培育的大鼠品系,即游泳测试易感大鼠(或易感大鼠),当其在游泳前暴露于轻度应激情况时,其在游泳测试中的主动行为表现出高度脆弱性。测试。研究发现,长期使用抗抑郁药物治疗可以消除这种脆弱性。长期使用其他精神活性药物治疗没有效果。因此,该测试似乎可用于检测抗抑郁药物,并将其与其他精神活性药物区分开来。第二种模型是一种新的抑郁症啮齿动物模型,其中动物在单次暴露于压力环境后表现出持久的抑郁症状(即持续 20-35 天)。在先前存在的啮齿动物模型中,抑郁样症状是暂时的(即持续 2-4 天);因此,以前的模型不允许在抑郁症状出现后服用药物,以便观察人类的恢复情况。这个新模型允许做到这一点。出现长期症状的模型使用另一种选择性繁殖的大鼠——过度活跃大鼠。除了在这些模型中测试药物外,还将在标准 Porsolt 游泳测试中对药物进行测试。最后,提出了动物模型的进一步开发。在这方面,我们将(a)尝试进一步完善多动大鼠作为双相情感障碍研究的潜在模型,以及(b)将我们选择性繁殖的大鼠进行母体分离,作为产生改进的情感障碍模型的可能手段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAY MICHAEL WEISS其他文献
JAY MICHAEL WEISS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAY MICHAEL WEISS', 18)}}的其他基金
A Neural Mechanism Underlying Alcohol Consumption and Its Increase with Stress
饮酒背后的神经机制及其随压力的增加
- 批准号:
8346585 - 财政年份:2012
- 资助金额:
$ 41.14万 - 项目类别:
A Neural Mechanism Underlying Alcohol Consumption and Its Increase with Stress
饮酒背后的神经机制及其随压力的增加
- 批准号:
8501164 - 财政年份:2012
- 资助金额:
$ 41.14万 - 项目类别:
A Neural Mechanism Underlying Alcohol Consumption and Its Increase with Stress
饮酒背后的神经机制及其随压力的增加
- 批准号:
8696596 - 财政年份:2012
- 资助金额:
$ 41.14万 - 项目类别:
Paradoxical Antidepressant Action in Locus Coeruleus during Development
蓝斑在发育过程中的矛盾抗抑郁作用
- 批准号:
7318974 - 财政年份:2007
- 资助金额:
$ 41.14万 - 项目类别:
Paradoxical Antidepressant Action in Locus Coeruleus during Development
蓝斑在发育过程中的矛盾抗抑郁作用
- 批准号:
7664392 - 财政年份:2007
- 资助金额:
$ 41.14万 - 项目类别:
Do antidepressants affect locus coeruleus consistently?
抗抑郁药是否持续影响蓝斑?
- 批准号:
6579257 - 财政年份:2002
- 资助金额:
$ 41.14万 - 项目类别:
Do antidepressants affect locus coeruleus consistently?
抗抑郁药是否持续影响蓝斑?
- 批准号:
6832174 - 财政年份:2002
- 资助金额:
$ 41.14万 - 项目类别:
Antidepressants - same effect on mesolimbic DA activity?
抗抑郁药 - 对中脑边缘 DA 活性有同样的影响吗?
- 批准号:
7417823 - 财政年份:2002
- 资助金额:
$ 41.14万 - 项目类别:
Do antidepressants affect locus coeruleus consistently?
抗抑郁药是否持续影响蓝斑?
- 批准号:
6685857 - 财政年份:2002
- 资助金额:
$ 41.14万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
脆性X综合征动物模型中异常视觉信息处理和视觉注意力的神经环路机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Optogenetic and chemogenetic regulation of uterine vascular function
子宫血管功能的光遗传学和化学遗传学调控
- 批准号:
10785667 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别:
Targeting Cholesterol Homeostasis to maintain vision in MS-like optic neuritis
针对多发性硬化症样视神经炎的胆固醇稳态以维持视力
- 批准号:
10657163 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别:
Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias
RyR 激动剂部分且受控地消耗 SR 钙可预防钙依赖性心律失常
- 批准号:
10577630 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别:
Protease-activated-receptor-2 antagonists for treatment of migraine pain
蛋白酶激活受体 2 拮抗剂治疗偏头痛
- 批准号:
10602826 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别:
Structurally engineered furan fatty acids for the treatment of dyslipidemia and cardiovascular disease
结构工程呋喃脂肪酸用于治疗血脂异常和心血管疾病
- 批准号:
10603408 - 财政年份:2023
- 资助金额:
$ 41.14万 - 项目类别: